1. Home
  2. NKSH vs RXST Comparison

NKSH vs RXST Comparison

Compare NKSH & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NKSH

National Bankshares Inc.

HOLD

Current Price

$36.57

Market Cap

233.8M

Sector

Finance

ML Signal

HOLD

Logo RxSight Inc.

RXST

RxSight Inc.

HOLD

Current Price

$5.54

Market Cap

232.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKSH
RXST
Founded
1891
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.8M
232.2M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
NKSH
RXST
Price
$36.57
$5.54
Analyst Decision
Hold
Analyst Count
0
10
Target Price
N/A
$9.78
AVG Volume (30 Days)
29.0K
1.4M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
4.22%
N/A
EPS Growth
100.81
N/A
EPS
0.78
N/A
Revenue
$8,176,000.00
$134,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.06
P/E Ratio
$48.62
N/A
Revenue Growth
9.39
N/A
52 Week Low
$27.00
$4.48
52 Week High
$40.00
$13.22

Technical Indicators

Market Signals
Indicator
NKSH
RXST
Relative Strength Index (RSI) 52.91 55.27
Support Level $34.87 $5.30
Resistance Level $38.08 $5.90
Average True Range (ATR) 1.18 0.47
MACD 0.05 0.06
Stochastic Oscillator 58.37 67.22

Price Performance

Historical Comparison
NKSH
RXST

About NKSH National Bankshares Inc.

National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural loans, commercial real estate, construction loans for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary. The company earns its revenue from interest and fees on loans, non-interest income, and investments.

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.

Share on Social Networks: